• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

drug launch

Crinetics Crinetics HQ Crinetics headquarters San Diego
Pharma

Crinetics breaks commercial barrier with Palsonify FDA nod

After nearly two decades in the endocrine scene, Crinetics is making its market debut with approval for a new oral drug in a rare hormone disorder.
Fraiser Kansteiner Sep 25, 2025 5:30pm
Sanofi

Sanofi's Wayrilz snags FDA endorsement in ITP

Aug 29, 2025 5:59pm
Leqembi IQLIK LEQEMBI IQLIK Eisai Biogen Leqembi

Eisai scores FDA nod for subcutaneous Leqembi maintenance dose

Aug 29, 2025 5:55pm
Iterum Orlynvah Iterum Therapeutics UTI

Breaking down Iterum's UTI antibiotic launch in the US

Aug 20, 2025 8:01am
Brinsupri

Insmed's Brinsupri nabs landmark FDA nod in chronic lung disease

Aug 12, 2025 12:05pm
JNJ

J&J logs strong innovative drug sales despite Stelara's decline

Jul 16, 2025 11:19am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings